May 3, 2027 — May 5, 2027
Bioethics International & EY’s 18th Annual Pharmaceutical Executive Roundtable on Ethics, Trust + Patient Centricity in Pharma. New York City.
The event date will be earlier next year on May 3rd, 4th or 5th. We will finalize soon.
The Roundtable is co-hosted with Yale Medicines Access Network (YMAN), Yale Program for Biomedical Ethics, and Scientific American.
This annual roundtable is the leading forum for senior leaders in healthcare, including industry, patient groups, and academia, to discuss the state of bioethics and patient centricity in medicine development and access and the role of the pharmaceutical sector.
May 3, 2027 — May 5, 2027
Bioethics International & EY’s 18th Annual Pharmaceutical Executive Roundtable on Ethics, Trust + Patient Centricity in Pharma. New York City.
The event date will be earlier next year on May 3rd, 4th or 5th. We will finalize soon.
The Roundtable is co-hosted with Yale Medicines Access Network (YMAN), Yale Program for Biomedical Ethics, and Scientific American.
This annual roundtable is the leading forum for senior leaders in healthcare, including industry, patient groups, and academia, to discuss the state of bioethics and patient centricity in medicine development and access and the role of the pharmaceutical sector.
July 15, 2026 — July 17, 2026
Jennifer Miller is honored to be speaking at The Oxford Global Health & Bioethics International Conference. On Wednesday July 15, she will address Accessibility of Medicine in Low- and Middle-Income Countries Hosting Trials for FDA Approvals.
The conference will focus on critical ethical issues in global health policy, practice and research that are most in need of sustained and substantial attention from researchers, funders and policy makers.
June 23, 2026
Patient-Powered Digital Health 2026,
Co-Designing Scalable Digital Health Solutions For A Trusted, Patient-First Future.
The meeting brings together patients, innovators, industry, healthcare providers and thought leaders to showcase and discuss the best innovations for the next generation of real-world, patient-centered solutions
Harvard Medical School, Boston, MA
June 8, 2026
Bioethics International & EY’s 17th Annual Pharmaceutical Executive Roundtable on Ethics, Trust + Patient Centricity in Pharma.
New York City.
May 17, 2026 — May 20, 2026
Jennifer Miller is speaking at ISPOR 2026.
Session: From Engagement to Strategy: An Evidence Based Framework for Evaluating Patient-Centricity in the Pharmaceutical Industry
Everyone says they’re “patient‑centric.” Patients don’t always feel it. Join our panel at ISPOR as industry leaders, patients, and academics unpack what meaningful patient‑centricity really requires. From ethical foundations to measurable performance indicators. Expect practical frameworks you can take back to your organization and actually use.
May 15, 2026
Jennifer Miller will be joining the REL Collaborative Learning Network
Connecticut Health Foundation, the Yale Equity Research and Innovation Center, and the Yale Global Health Leadership Initiative
May 15, 2026, New Haven, CT
May 8, 2026 9.05 - 4.55
The Cancer Bioethics Consortium, in collaboration with the Ethics Committee at Memorial Sloan Kettering Cancer Center, presents a virtual conference.
“Hard Choices: Ethics in Modern Oncology” welcomes both clinicians and non-clinicians seeking to better understand the ethical issues that shape oncology practice and research. Jennifer E. Miller, PhD, will be presenting a keynote on Pharma Scoring at 11.30am.
